RRI and Azura Vascular Care and National Cardiovascular Partners are working together on vascular imaging using artificial intelligence and machine learning.

RRI and the Boston University School of Public Health (BUSPH) conduct research into the impact of climate change on health outcomes in kidney patients.

The Nephrology department of the Catharina Hospital Eindhoven is one of the largest renal care facilities in the Netherlands. Here patients with kidney disease receive state of the art treatment and clinical research programs with great translational ambition. The Catharina Hospital offers ample opportunities for Master and PhD student. Our strength is our knowledge and expertise, nourished by training and research. The mission of Dr. S. Konings, leading nephrologist, is to advance self-management and renal replacement therapy at home. Furthermore the peritoneal dialysis for chronic heart failure is a focal point. He participates in worldwide ground-breaking research and presides the Dutch Nephrology Days. RRI collaborates with the Catharina Hospital Eindhoven and Dr. S. Konings on the MONDO initiative.

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the University to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

RRI and Joanneum Research conduct joint research on tissue sodium storage.

RRI and Karlsruhe Institute of Technology (KIT) collaborate on the mathematical modeling of the cardiac conductance system with applications in dialysis patients. As “The Research University in the Helmholtz Association” unites the missions of a German university of excellence with a national large-scale research center. KIT's Institute of Biomedical Engineering performs cutting-edge interdisciplinary research together in clinical medicine and industry to investigate new systems that help early disease diagnoses and establish successful therapies. The Computational Cardiac Modeling Group develops heart models and applies cardiological problems focusing on electrophysiology and elastomechanics.

Maastricht University Hospital is one of RRI's longest-standing partners. Researcher from both institutions collaborate on a wide range of projects, including basic and clinical research.

RRI and Professor Sandip Mitra at Manchester Academy Health Sciences Centre & Manchester University Hospitals, NHS collaborate on research in vascular access biology and hemodialysis.

RRI and Medical University of Innsbruck, Department of Internal Medicine IV - Nephrology and Hypertension, have a close collaboration in the area of CKD-MBD.

RRI and Icahn School of Medicine collaborate on basic and clinical research related to anemia and COVID-19.

RRI and INC collaborate on projects related to uremic toxicity and enhanced removal of protein bound uremic toxins.

RRI has collaborated with Dr. Lars Penne in various research projects and he has been a visiting scientist at RRI focusing in areas of hemodialysis and hemodiafiltration. Dr. Penne is affiliated with Northwest Clinics which is a top clinical hospital, providing more than the customary specialty medical care, and covering several regions in The Netherlands; Alkmaar, Den Helder, Heerhugowaard, Limmen, Schagen and Texel. The clinics serve a population of more than 600,000. Northwest Clinics stands for good quality of service and care, in consequence its patients count with the best treatment possible under all conditions. Routine procedures are organized quickly and effectively. Chronic illnesses receive the guidance and continuity of care that they need, close to home.

RRI and Pontificia Universidade Católica do Paraná (PUCPR, Brazil) collaborate on a wide range of projects. Since 2011, PUCPR has been a RRI partner in basic and clinical research projects. The basic research projects emphasize renal anemia and mechanisms that can prolong the erythrocyte lifespan positively on the patient's quality of life. The clinical research projects are focused on hemodialysis, related to the HDFit initiative and peritoneal dialysis studies. PUCPR is currently the coordinator center of the PD-MONDO initiative, one of the world's largest PD cohorts. The exchange of master's and doctorate students between institutions has been essential in strengthening the partnership.

RRI collaborated with the TNMU in the area of CKD-MBD.

RRI and University of California Santa Barbara (UCSB) partner for more than a decade on research into the epidemiology of kidney disease. At UCSB, we thrive on the vital exchange of ideas and experiences across our campus. It is only fitting that we have the tools to capture the spirit of our dynamic environment with consistency and character wherever we can. To that end, we have developed a visual system and accompanying guidelines to better reflect the real UCSB across everything we do.

RRI and KFU Graz collaborate on mathematical modeling of physiological systems.

RRI and The Hospital Civil of Guadalajara (HCG) conducts together research into the epidemiology of Chronic Kidney Disease (CKD). HCG is a large tertiary health care organization in western Mexico, offering comprehensive medical care to patients free of charge. With two hospital facilities, 1709 beds, and 48 specialty programs, is also the largest teaching and clinical research facility of the University of Guadalajara Health Sciences Center. The Nephrology Service pioneered the provision of dialysis and transplantation, as well as screening and prevention of CKD for the poor. Since 2008, the nephrology fellowship program has been recognized by Mexico’s Council on Science and Technology as a center of International Competence.

RRI and University of Konstanz (KFU) Graz collaborate on mathematical modeling of control systems and medical applications. KFU is motivated by real application, e.g., in therapy planning, in energy supply networks or in pandemic we are interested in developing optimal strategies and in estimating unknown parameters. For this purpose, we design and analyze efficient numerical methods. We utilize model-order reduction (ROM) in order to replace complex dynamical systems by low-dimensional ones with certified error control. ROM enables us to calibrate and optimize models given by systems of partial differential equation models.

RRI has collaborated with Dr. Maria E. Diaz-Gonzalez de Ferris and her laboratory at the University of North Carolina Department of Pediatrics for many years. Dr. Ferris and her team have competed and secured the funding of multiple projects that focus on improving the lives of adolescents and young adults with chronic kidney disease (CKD) or end-stage kidney disease. These projects include the development of health care transition tools, patient/parent education material on kidney health and the management of kidney disease and the life course of CKD.

RRI and the UMCG collaborate in the field of acid base metabolism in hemodialysis patients. Clinical data collected by researchers at the UGMC are analysed at the RRI using mathematical models. The goal of this research is to better understand the impact of dialysis prescription on acid base metabolism.

RRI and Virinchi Hospitals collaborate closely on the development of innovative dialysis technologies.

The Weill Cornell Medical Center (WCMC) is a leading U.S. hospital and research institution. WCMC and RRI collaborate in the field of biomedical imaging. Specifically, we collaborate on the imaging of tissue sodium storage in skin and muscle using 23Na MRI. Kidney patients are prone to accumulate sodium in tissues, a condition that may exacerbate metabolic and cardiovascular complications.